Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Drugs

Drugs


                Regulatory Science Research and Education
          Development & Approval Process | Drugs
          Drug Safety and Availability
          Emergency Preparedness | Drugs
          Guidance, Compliance, & Regulatory Information
          News & Events for Human Drugs
          Resources | Drugs
          Science and Research | Drugs Home Drugs
  
  			 
		The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United StatesTopic Paragraphs
          Recent NewsWoman and man yelling.

                    FDA's ISTAND Pilot Program accepts new submission
            Submission is first AI-based and digital health technology-based project
    
          White graphic with text overlay reading Drug Safety Communications. On the left side of the graphic is an image of multi-colored pills.

                    Osteoporosis drug Prolia increases the risk of severe hypocalcemia
            Patients on dialysis or with mineral and bone disorder at highest risk
    
          Blue capsules on conveyor at modern pharmaceutical factory.

                    New webpage for searching pharmaceutical quality resources
            Page improves access to relevant and up-to-date resources and information
          Recent NewsNew Drug Therapy Approvals 2023 Report Cover

                    FDA publishes annual report highlighting new drug approvals
            Illustrates CDER’s role in advancing health through innovation
    
          White graphic with text overlay reading Drug Safety Communications. On the left side of the graphic is an image of multi-colored pills.

                    FDA evaluating risk of suicide with diabetes and obesity drugs
            Preliminary results do not suggest a causal link
    
          Woman yelling into megaphone

                    FDA approves promethazine hydrochloride injection labeling updates
            Changes mitigate risk of irritation and tissue damage
          Navigate the Drugs SectionDrug Information, Safety, and Availability
        Medication Guides, Drug Safety Communications, Shortages, RecallsDrug Approvals and Databases
        Drugs@FDA, Orange Book, National Drug Code, Recent drug approvalsDrug Development and Review Process
        Drug applications, submissions, manufacturing, and small business helpGuidance, Compliance, and Regulatory Information
        Guidances, warning letters, drug compounding, international information, registration and listingRegulatory Science and Research
          CDER research programs, initiatives, and resourcesEmergency Preparedness
          Prepare and respond to natural disasters, nuclear and chemical attacksUpdates, News, Events, and Training
          Recent approvals, meetings, workshops, blogs, podcasts, stay connectedAbout the Center for Drug Evaluation and Research (CDER)
          Our role, mission, organization, history, leadership, job openings
          FDA InitiativesTwo men standing on an outdoor basketball court.
      

            
      Don’t Get Burned is a component of FDA’s national campaign to raise awareness about sun safety and encourage proper sunscreen use and application.

                    FDA Health Playbook Campaigns
            PSAs inform consumers about the safe use and disposal of FDA-regulated products
    
          Two young women hugging while at home.
      

            
      The overdose crisis is an evolving public health crisis.

                    FDA Overdose Prevention Framework
            The agency and HHS are working together to address the public health emergency
    
          Zebra underneath a blue back ground with light rainbow streak.

                    Accelerating Rare disease Cures (ARC) Program
            New initiative supports delivery of treatments for patients with a rare disease
          Priority Areas & InitiativesCoronavirus (COVID-19)
        Get the latest news and information regarding the global pandemicOpioids
        Reducing the impact of opioid misuse and abuseGenerics
        Ensuring access to safe, affordable, and effective generic drugsWarning Letters
        Warning and Notice of Violation Letters to Pharmaceutical CompaniesGuidances
          FDA's current thinking on drug development and review activitiesDrug Shortages
          Search the database, learn about root causes and potential solutionsResources
          Information for consumers, health professionals, and industryDisposal of Unused Medicines
          Learn how to properly get rid of unused or expired medication
          CENTER FOR DRUG EVALUATION AND RESEARCH
              
            
            Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
      
	druginfo@fda.hhs.gov
      
	
	Toll Free
      
		
            (855) 543-3784
      
		
		
            (301) 796-3400
      
		
	
		
	Hours Available

	
		CDER Division of Drug Information

    Paragraph Header (Column 2)
              FOR UPDATES ON X FOLLOW
              
                  
            @FDA_Drug_Info

		 	 		
  	

	Your source for the latest drug information.
Know the moment it happens.
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop